English
Wockhardt Q2 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
1,333.25
11.25 (0.85%)
11.25 (0.85%)Volume69.00 K
Updated: Wed 10 Dec, 2025 | 15:51:50
NSE
1,333.5011.60 (0.88%)
11.60 (0.88%)Volume1.14 M
Updated: Wed 10 Dec, 2025 | 15:54:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹782.00 Cr.(-3.34%)
- Operating Profit₹107.00 Cr.(42.67%)
- Profit After Tax₹78.00 Cr.(NA%)
- Operating Margin13.68%(47.59%)
Note: Comparison is on YoY basis
Quarterly - Wockhardt Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 675.00 | 790.00 | -14.56% | 734.00 | -8.04% |
| Depreciation/ Amortization | 53.00 | 56.00 | -5.36% | 55.00 | -3.64% |
| Operating Income | 107.00 | -52.00 | 0.00% | 75.00 | 42.67% |
| Net Income | 78.00 | -90.00 | 0.00% | -22.00 | 0.00% |
| Other Operating Expenses Total | 203.00 | 202.00 | 0.50% | 221.00 | -8.14% |
| Net Income Before Taxes | 91.00 | -,109.00 | 0.00% | -9.00 | 0.00% |
| Total Revenue | 782.00 | 738.00 | 5.96% | 809.00 | -3.34% |
| Selling/ General/ Admin Expenses Total | 186.00 | 171.00 | 8.77% | 161.00 | 15.53% |
| Diluted Normalized EPS | 4.81 | -1.66 | 0.00% | -1.47 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.